Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
0.9058
-0.0105 (-1.15%)
At close: Oct 12, 2026, 4:00 PM EDT
0.9150
+0.0092 (1.02%)
After-hours: Oct 12, 2026, 7:52 PM EDT
Aldeyra Therapeutics Stock Forecast
ALDX's stock price has decreased by -83.19% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 6 analysts polled by S&P Global, Aldeyra Therapeutics stock has a consensus rating of "Buy" and an average price target of $6.60. The average 1-year stock price forecast is 628.64% higher than the current stock price, while the lowest is $2.00 (+120.80%) and the highest is $13 (+1,335.20%).
Price Target: $6.60 (+628.64%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Aldeyra Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 5 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates $2 | Hold | Reiterates | $2 | +120.80% | Sep 30, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
6.72M
EPS This Year
-0.34
from -0.56
EPS Next Year
-0.28
from -0.34
EPS and Forward PE are based on non-GAAP adjusted numbers.